OVERVIEW

In this webinar, we discuss methods to help you be successful in obtaining a prior authorization for diabetes medication and technology. You’ll learn how to apply workflow models that can be used by the diabetes care team to receive prior authorization for insulin, SGLT-2 inhibitors, GLP-1 receptor agonists, and diabetes technology for varying types of insurance. Panelists highlight payor considerations for Medicare, Medicaid and commercial health plans. Thank you to our webinar collaborators ASHP (American Society of Health-System Pharmacists) and ACOFP (American College of Osteopathic Family Physicians).

LEARNING OBJECTIVES

1. Identify methods to be successful in obtaining a Prior Authorization for diabetes medication and technology

2. Apply workflow models that can be used by the diabetes care team to receive prior authorization for insulin, SGLT-2, GLP-1, and diabetes technology for varying types of insurance 

EXPIRATION DATE

November 1, 2025

Alex Turchin, MD

Brigham and Women's Hospital 

Eden Miller, DO

ACOFP, Diabetes Nation 

Lucia Novak, NP

Capital Diabetes and Endocrine Associates 

Kayla Wegner, PharmD

ASHP, ThedaCare Physician Group

Note: You do not need to be an ADA professional member to access our free continuing education programs. Simply create a free account and start exploring 70+ free CE courses. Login to get started!